Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 50:1752-1758, doi:10.1016/j.jacc.2007.04.101 (Published online 12 October 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, M.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Singh, M.
Right arrow Articles by Holmes, D. R., Jr
Related Collections
Right arrowRelated Article

Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock

Insights From the GUSTO-I Trial

Mandeep Singh, MD*, Jennifer White, MS{dagger}, David Hasdai, MD{ddagger}, Patricia K. Hodgson, BA{dagger}, Peter B. Berger, MD§, Eric J. Topol, MD||, Robert M. Califf, MD{dagger} and David R. Holmes, Jr, MD*,*

* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
{dagger} Duke Clinical Research Institute, Durham, North Carolina
{ddagger} Rabin Medical Center, Petah Tikva, Israel
§ Geisinger Clinic, Danville, Pennsylvania
|| Scripps Research Institute, La Jolla, California.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Hazard Ratios for All 30-Day Survivors

Hazard ratios with (red circles) and without (blue squares) cardiogenic shock. Factors analyzed include baseline characteristics, cardiac history, treatment group, and procedures undergone during index hospitalization. All continuous variables (age, weight, height, heart rate, and systolic and diastolic blood pressure) were measured in units of 1 (e.g., respectively, 1 year, 1 kg, 1 cm, 1 beat/min, and 1 mm Hg), so that patients with a variable that measured 1 U greater than another patient had a hazard of mortality as reflected in the figure. For example, a nonshock 65-year-old patient had a 1.06 greater hazard of dying than a nonshock 64-year-old patient. BP = blood pressure; CABG = coronary artery bypass grafting; CVD = cerebrovascular disease; dia = diastolic; IABP = intra-aortic balloon pump; IV Hep = intravenous heparin; MI = myocardial infarction; PTCA = percutaneous transluminal coronary angioplasty; SK = streptokinase; SubQ Hep = subcutaneous heparin; sys = systolic; t-PA = tissue plasminogen activator.

 

Figure 2
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Kaplan-Meier Mortality Curve in 30-Day Survivors of STEMI

The Kaplan-Meier mortality estimate at 11 years is 44.8% (95% confidence interval 41.6 to 47.9) in patients with (red line)and 30.6% (95% confidence interval 29.9 to 31.2) in patients without (blue line) shock. STEMI = ST-segment elevation myocardial infarction.

 

Figure 3
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Bar Graph Showing Annual Mortality in STEMI Patients Presenting With and Without Shock

Mortality rates beyond the first year are similar. STEMI = ST-segment elevation myocardial infarction.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement